Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis.

Amit KumarEra KarnKiran TrivediPramod KumarGanesh ChauhanAradhana KumariPragya PantMurali MunisamyJay PrakashPrattay Guha SarkarKameshwar PrasadAnupa Prasad

Published in: PloS one (2022)

Procalcitonin has good discriminatory power for predicting mortality and disease severity in COVID-19 patients. Therefore, procalcitonin measurement may help identify potentially severe cases and thus decrease mortality by offering early aggressive treatment.

Keyphrases

sars cov
cardiovascular events
coronavirus disease
risk factors
early onset
type diabetes
coronary artery disease
cardiovascular disease